Seeking Alpha: Theravance Biopharma Launches Disease Education Campaign to Advance Scientific Understanding of Neurogenic Orthostatic Hypotension Due to Multiple System Atrophy Theravance Biopharma Launches Disease Education Campaign to Advance Scientific Understanding of Neurogenic Orthostatic Hypotension Due to Multiple System Atrophy Seeking Alpha: Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous ... Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous ... Medical Xpress: Nervous System Diseases: News and Research on Postural Orthostatic Tachycardia Syndrome DUBLIN--(BUSINESS WIRE)-- Theravance Biopharma, Inc.
(TBPH) today announced the launch of “Power in the Periphery,” a new disease education campaign for healthcare professionals (HCPs) to raise ... NEW ORLEANS — For patients with prior stroke, a lower systolic blood pressure (SBP) goal actually reduced the occurrence of orthostatic hypotension and did not lead to more dizziness or ... Sitting and sedentary behavior are linked to a higher risk of many health conditions, including cardiovascular disease. Standing isn’t enough to offset the negative health effects of a sedentary ...
